Molecule Details
| InChIKey | XFJAMQQAAMJFGB-ZQGJOIPISA-N |
|---|---|
| Canonical SMILES | CCc1ccc([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1Cc1ccc2c(c1)OCCO2 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 9.3 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB15048 |
|---|---|
| Drug Name | Licogliflozin |
| CAS Number | 1291094-73-9 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Licogliflozin is under investigation in clinical trial NCT03320941 (A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity). |
Categories: Alcohols Blood Glucose Lowering Agents Carbohydrates Sodium-Glucose Transporter 2 Inhibitors Sugar Alcohols
Cross-references: ChemSpider: 71045806